Novartis Magyarország’s Post

hyperCORE International, a leading clinical research organization, has welcomed CaRe Clinic, a multi-specialty research organization based in Alberta, Canada, to its collaborative super network of clinical trial sites. This partnership expands hyperCORE's global reach and capabilities through strategic alliances. CaRe Clinic operates two state-of-the-art research centers in Calgary and Red Deer, with expertise in areas such as women's health, dermatology, and infectious diseases. The organization has access to a vast patient pool of over 1.8 million potential participants through investigator databases and partnerships with affiliated clinics. 'At CaRe Clinic, we are continuously looking for opportunities to improve how we deliver clinical trials,' said Troy Hamilton, Director of Operations at CaRe Clinic. 'This partnership opens doors for unprecedented collaboration and the sharing of best practices across borders, which is crucial for the advancement of clinical research.' Carlos Orantes, President of hyperCORE and CEO at alliance partner Alcanza Clinical Research, expressed enthusiasm about the partnership, stating, 'hyperCORE welcomes CaRe Clinic to their super network with open arms. This immediately increases hyperCORE's footprint at multiple locations in Canada with a multi-therapeutic offering and adds a solid partner to the team.' @hypercoreinternational @careclinic #clinicalresearch #partnership #collaboration #globalreach #patientrecruiment

 Institución:IIS Aragon (Zaragoza)  Contacto correo-e:pmbaptista@iisaragon.es --- Project Summary: In Spain, between 20-25% of livers and kidneys donated for transplantation are currently wasted due to problems such as hepatic steatosis (>30%) or prolonged warm ischemia (>2h). However, recent advances in dynamic normothermic machine perfusion (NMP) have made it possible to maintain these organs in conditions closer to their natural physiologic microenvironment. Prolonged NMP in the liver (and kidney) opens the door to the regeneration of marginal organs before transplantation. Thus, our proposal focuses on the development of ex vivo cell therapy with mesenchymal stem cells (MSCs) applied to marginal organs, such as steatotic livers and kidneys with prolonged ischemia, that have been previously rejected for transplantation. This procedure will be carried out using state-of-the-art technology. Subsequently, human marginal organs regenerated by this advanced therapy under prolonged NMP conditions will be transplanted into immunodeficient pigs (SCID) to assess their survival, viabilit  y, and medium-term function. The success of this project will boost the adoption of organ regeneration techniques using NMP and ex vivo cell therapy, which could significantly increase the global availability of livers and kidneys for transplantation, with a special focus on meeting the needs of elderly patients suffering from chronic and oncological diseases. Who we are: We are a consolidated multidisciplinary research team (Digestive Pathology and Hepatology Research Group, led by Dr. Angel Lanas) with one of Aragon's highest publication impact factors. The work will be done at the Organ Bioengineering and Regenerative Medicine Laboratory led by Dr. Pedro Baptista.  ---------------- Información complementaria de la oferta: What we offer: 2-year full-time contract (6 months trial period) with the chance for long-term stabilization at the collaborating company EBERS Medical SL, or apply to competitive grants at IIS Aragon (Marie Curie, Sara Borrell, Miguel Servet) for a longer/permanent time. Flexible working hours. Multidisciplinary environment. International networking opportunities. Soft-skills development. Conditions of the employment: A standard postdoc contract (2 year), with a salary of 34,000 €/year. The post is immediately available. Later dates can be considered. How to apply? https://lnkd.in/dfVvAfXz Email: organbioengineeringlab@gmail.com The application deadline is June 28, 2024.

Check out our latest news from SAOA2024.

🚀 Exploring the Future of Healthcare: Meetings involved in the Horizon Scanning Unit 🌐 Assalamualaikum & a very good day to everyone. We're excited to shed light on the crucial inner workings of our Horizon Scanning Unit, paving the way for innovative healthcare solutions. 🌟 1. Filtration Meetings (6 times/year) Our diligent MaHTAS staff will conduct the Filtration Meetings in-house for at least six times per year, using the predefined criteria to gather comprehensive information about technologies. The team discusses and decides on the technology for prioritisation exercise, based on innovativeness and high burden or importance. 2. Technical Advisory Committee for Horizon Scanning (TAC HS) Meetings (3 times/year) The Technical Advisory Committee for Horizon Scanning (TAC HS) is composed of policy makers, clinicians, researchers, and representatives from agencies involved in healthcare innovations. This includes the Medical Device Authority, National Pharmaceutical Regulatory Agency (NPRA), Medical Radiation Surveillance Division, Engineering Division, Oral Health Division, Traditional and Complementary Medicine (T&CM) Division, Ministry of Science, Technology and Innovation (MOSTI), SIRIM Berhad and MIGHT, representative from related clinical services (e.g. Medical, Surgery, Radiology, Pathology). Other experts may also be invited as opt-in member if required. The committee decides on prioritisation of high impact, filtered technologies for further detailed assessment and subsequent endorsement by the Council. 3. HTA & CPG Council Meetings (2 times/year) The Health Technology Assessment and Clinical Practice Guidelines Council is the highest authority that sets the direction of horizon scanning activity and endorses horizon scanning reports. The Council is chaired by the Director General of Health and the members consist of all the Deputy Director General of Health, the Senior Directors and Directors of relevant divisions within the Ministry of Health, Deans of Medical Faculty, representatives of the Malaysian Medical Association, Academy of Medicine Malaysia, Association of Private Hospital Malaysia and clinicians. Stay tuned for more updates and join us in shaping the future of healthcare! #mahtas #HorizonScanning #futureofhealthcare Dr Izzuna Ghazali

The Namibia institute of Pathology (NIP) embarked on a transformational journey with its Integrated Strategic Business Plan (ISBP) 2022-2027 named Za Tuka, which translates to ‘the plane has taken off’ in Rukwangali, two years ago. This ambitious five-year plan is demonstrably proving its worth, yielding significant progress towards its goals of optimising shareholder value and solidifying NIP’s role as a leading force in Namibia’s healthcare landscape. As NIP looks towards the remaining three years of the plan, its commitment to delivering exceptional service and driving positive change in the healthcare sector remains unwavering. https://lnkd.in/eTmzH8Rs

Congratulations! 🏆 🎉 Team QREC Clinical Research LLP (India-UAE) for INITIATING the Real World, Observational study on Cardiac molecule "Angio seal PCI" with 10 KOL Cardiologist's and 100 patients across PAN India. #cro #clinicaldatamanagement #medicalwriting  #clinicaloperations #OBSERVATIONALSTUDY  #statisticalanalysis #clinicalresearch #clinicaltrials  #clinicaldata #medicalwriting #statisticalprogramming #contractresearchorganization #publications  #submission #manuscripts #REALWORLDSTUDY  #doctors #regulatoryaffairs #projectmanagement  #qualitycontrol #sitemanagementb #medicaldevices  #pharmaceuticalsindustry #lifesciences

Congratulations! 🏆 🎉 Team QREC Clinical Research LLP (India-UAE) for INITIATING the Real World, Observational study on Cardiac molecule "Angio seal PCI" with 10 KOL Cardiologist's and 100 patients across PAN India. #cro #clinicaldatamanagement #medicalwriting  #clinicaloperations #OBSERVATIONALSTUDY  #statisticalanalysis #clinicalresearch #clinicaltrials  #clinicaldata #medicalwriting #statisticalprogramming #contractresearchorganization #publications  #submission #manuscripts #REALWORLDSTUDY  #doctors #regulatoryaffairs #projectmanagement  #qualitycontrol #sitemanagementb #medicaldevices  #pharmaceuticalsindustry #lifesciences

Congratulations! 🏆 🎉 Team QREC Clinical Research LLP (India-UAE) for INITIATING the Real World, Observational study on Cardiac molecule "Angio seal PCI" with 12 KOL Cardiologist's and 90 patients across PAN India. #cro #clinicaldatamanagement #medicalwriting  #clinicaloperations #OBSERVATIONALSTUDY  #statisticalanalysis #clinicalresearch #clinicaltrials  #clinicaldata #medicalwriting #statisticalprogramming #contractresearchorganization #publications  #submission #manuscripts #REALWORLDSTUDY  #doctors #regulatoryaffairs #projectmanagement  #qualitycontrol #sitemanagementb #medicaldevices  #pharmaceuticalsindustry #lifesciences

Congratulations! 🏆 🎉 Team QREC Clinical Research LLP (India-UAE) for INITIATING the Real World, Observational study on Cardiac molecule "Angio seal PCI" with 12 KOL Cardiologist's and 90 patients across PAN India. #cro #clinicaldatamanagement #medicalwriting  #clinicaloperations #OBSERVATIONALSTUDY  #statisticalanalysis #clinicalresearch #clinicaltrials  #clinicaldata #medicalwriting #statisticalprogramming #contractresearchorganization #publications  #submission #manuscripts #REALWORLDSTUDY  #doctors #regulatoryaffairs #projectmanagement  #qualitycontrol #sitemanagementb #medicaldevices  #pharmaceuticalsindustry #lifesciences

Congratulations! 🏆 🎉 Team QREC Clinical Research LLP (India-UAE) for INITIATING the Real World, Observational study on Cardiac molecule "Angio seal PCI" with 10 KOL Cardiologist's and 100 patients across PAN India. #cro #clinicaldatamanagement #medicalwriting  #clinicaloperations #OBSERVATIONALSTUDY  #statisticalanalysis #clinicalresearch #clinicaltrials  #clinicaldata #medicalwriting #statisticalprogramming #contractresearchorganization #publications  #submission #manuscripts #REALWORLDSTUDY  #doctors #regulatoryaffairs #projectmanagement  #qualitycontrol #sitemanagementb #medicaldevices  #pharmaceuticalsindustry #lifesciences